PEDIATRICS Vol. 64 No. 3 September 1979, pp. 342-347
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beale, E. F.
Right arrow Articles by Eitzman, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beale, E. F.
Right arrow Articles by Eitzman, D. V.

Intrahepatic Cholestasis Associated with Parenteral Nutrition in Premature Infants

E. F. Beale MD1, R. M. Nelson MD1, R. L. Bucciarelli MD1, W. H. Donnelly MD1, and D. V. Eitzman MD1

1 Department of Pediatrics, Division of Neonatology, University of Florida College of Medicine, Gainesville, Florida

Sixty-two premature infants less than 2,000 gm birth weight received parenteral nutrition (PN) during periods of respiratory distress with feeding intolerance. Intrahepatic cholestasis (direct bilirubin ge 1.5 mg/dl) associated with PN developed in 14 or 23% of these infants. The mean time on PN to onset of cholestasis was 42 days, and the cholestasis persisted as long as the infants continued to receive PN. All five infants who had serial follow-up laboratory studies showed an eventual return of direct bilirubin levels to normal. The direct bilirubin level appeared to be the best clinically available test to monitor for the onset and to follow the resolution of this complication. The very low birth weight infants < 1,000 gm appeared to be at an increased risk of developing cholestasis with an incidence of 50%. However, there was no correlation between the length of time PN was administered to onset of cholestasis and the gestational age or birth weight of the infants. These tiny premature infants also received PN for significantly longer periods of time, and the longer the infusions were administered the greater was the risk of cholestasis developing.

Submitted on July 7, 1978
Accepted on February 12, 1979




This article has been cited by other articles:


Home page
 NeoReviewsHome page
C. Colby, T. Hartman, and T. Lang
Pharmacology Review: Pharmacotherapy for the Treatment of Parenteral Nutrition-associated Cholestasis
NeoReviews, December 1, 2007; 8(12): e547 - e550.
[Full Text] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
P. D. S. Loff, U. Subotic, J. Oulmi-Kagermann, B. Kranzlin, M.-F. Reinecke, and C. Staude
Diethylhexylphthalate Extracted by Typical Newborn Lipid Emulsions From Polyvinylchloride Infusion Systems Causes Significant Changes in Histology of Rabbit Liver
JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 188 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
V. J. Kumpf
Parenteral Nutrition-Associated Liver Disease in Adult and Pediatric Patients
Nutr Clin Pract, June 1, 2006; 21(3): 279 - 290.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. H. Teitelbaum, T. F. Tracy Jr, M. M. Aouthmany, A. Llanos, M. B. Brown, S. Yu, M. R. Brown, R. J. Shulman, R. B. Hirschl, P. A. Derusso, et al.
Use of Cholecystokinin-Octapeptide for the Prevention of Parenteral Nutrition-Associated Cholestasis
Pediatrics, May 1, 2005; 115(5): 1332 - 1340.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. J. I. J. Albers, D.-A. H. de Gast-Bakker, N. A. M. van Dam, G. C. Madern, and D. Tibboel
Male Sex Predisposes the Newborn Surgical Patient to Parenteral Nutrition-Associated Cholestasis and to Sepsis
Arch Surg, July 1, 2002; 137(7): 789 - 793.
[Abstract] [Full Text] [PDF]